Brind.

Abbott and Boost offer nutritional products to consumers, with Similac remaining a top choice for American parents.

1 report, 1 independent Updated Aug 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Abbott Laboratories Boost

Keep exploring

The entities involved

Abbott Laboratories
American global health care and medical device products company
- MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.Sun 18:28
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.Sun 07:04
Boost
British drinks company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 18ZacksAbbott Gains in Nutrition With Adult Segment Leading Growth Abbott Laboratories’ ABT Nutrition business has consistently demonstrated strong growth and market share gains. This segment offers a broad